Cadila Healthcare unit inks pact to sell two brands to Integrace

By: |
September 20, 2021 6:31 PM

Zydus Healthcare Ltd, a wholly-owned subsidiary of the company, has inked the agreement with Integrace, a part of the portfolio companies of private equity firm True North.

"The said transaction is expected to be completed within 30 days from the date of execution of agreement, subject to customary approvals," Cadila Healthcare said in a regulatory filing."The said transaction is expected to be completed within 30 days from the date of execution of agreement, subject to customary approvals," Cadila Healthcare said in a regulatory filing.

Cadila Healthcare on Monday said its subsidiary has inked a pact with Integrace Pvt Ltd to sell two brands — Mifegest and Cytolog.

Zydus Healthcare Ltd, a wholly-owned subsidiary of the company, has inked the agreement with Integrace, a part of the portfolio companies of private equity firm True North.

“The said transaction is expected to be completed within 30 days from the date of execution of agreement, subject to customary approvals,” Cadila Healthcare said in a regulatory filing.

The company, however, did not share the financial details of the deal. Cadila shares ended 2.08 per cent down at Rs 546.35 apiece on Monday.

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, Check out latest IPO News, Best Performing IPOs, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.

Next Stories
1VIL to opt for 4-year moratorium on spectrum payments
2Instagram to let users post photos from desktop, collab with friends and share likes
3Jio gains 6.49 lakh mobile users in Aug; Airtel adds 1.38 lakh